Skip to main content

Advertisement

Table 1 Characteristics of studies that used a symptom assessment scale in pediatric oncology

From: A systematic review of symptom assessment scales in children with cancer

Author Year Instrument Mean age in years ± SD or (range) Number enrolled Respondent Timing ** Once or multiple ***
Baggott[18] 2011 MSAS 10-18 14.7 ± 2.8 66 Child During Multiple
Wu[19] 2011 SDS NS 40 Child During Once
Gibson[16] 2010 ASyMS-YG 15* (13–18) 27 Child During Multiple
Poder[3] 2010 MSAS 10-18 NS 292 Parent During Multiple
Walker[20] 2010 MSAS 7-12 14.2 + 2.7 51 Child During Multiple
Dupuis[17] 2009 Unique 9.4 ± 6.8 200 Parent During Once
Sitaresmi[21] 2009 Unique 6* (2–16) 61 Parent During Once
Yeh[22] 2009 MSAS 10-18 14.2 + 2.2 144 Parent Both Once
Williams[23] 2006 TRSC-C 10.4 ± 6.1 11 Parent During Once
Collins[24] 2002 MSAS 7-12 9.6 (7–12) 149 Child Both Multiple
Hinds[25] 2002 SDS 15.5 ± 2.1 77 Child During Multiple
Collins[26] 2000 MSAS 10-18 14 (10–18.2) 160 Child Both Multiple
Berard[27] 1998 RSCL 16.9 43 Child During Multiple
Eiser[28] 1997 RSCL 14.5 (4–19) 47 Parent Both Once
  1. *Median; **Timing refers to whether instrument was administered during active treatment only or both during and following completion of chemotherapy; ***Instrument administered once or more than once.
  2. Abbreviations: ASyMS-YG Advanced Symptom Management System – Young, MSAS Memorial Symptom Assessment Scale, SDS Symptom Distress Scale, TRS-C Therapy-related Symptom Checklist, RSCL Rotterdam Symptom Checklist, SD standard deviation, NS not stated.